| Polly Roy | |
| Honorific Suffix: | OBE |
| Birth Place: | Calcutta, India |
| Workplaces: | London School of Hygiene and Tropical Medicine |
Polly Roy OBE is a professor and Chair of Virology at The London School of Hygiene and Tropical Medicine.[1] [2] She attended a number of schools which included Columbia University Medical School, Rutgers University, University of Alabama, and University of Oxford. In 2001 she became a part of The London School of Hygiene and Tropical Medicine and, along with being the chair of Virology, is also the co-organiser of the medical microbiology course.The virus that she has dedicated most of her career to is Bluetongue disease that affects sheep and cattle. She became interested in this virus after attending a symposium and was intrigued by the fact that not much was known about the virus that was causing such a nasty and sometimes fatal disease.
Roy went to Presidency College in Calcutta, India, where she was born. Thereafter, she received a scholarship to study at New York University where she received her PhD in Molecular Virology. Whilst studying biological sciences she met biologist Sol Spiegelman. Roy then spent three years in a post-doctoral position in RNA Virology at Waksman Institute of Microbiology at Rutgers University. After her post-doctoral work, she went to the University of Alabama at Birmingham to begin her own RNA research group. She became a professor at University of Alabama at Birmingham in 1987. Roy then received the Fogarty Fellowship at the University of Oxford in 1997 where she established a second virology lab. In 2001 Roy moved to The Department of Pathogen Molecular Biology at the London School of Hygiene and Tropical Medicine[3] as a Virology professor where she leads a research groups.
Throughout her career, Roy has improved understanding on basic molecular, and structural biology, replication and the transmission of a variety viruses.
Her research has led to advances in the development of improved diagnostic assays, more efficacious virus-like protein (VLP) vaccines, vaccines for Bluetongue and African Horse sickness virus (AHSV) and the possibility of other therapeutics relating to these diseases.[4]
Roy's research[5] has been published in multiple highly acclaimed journals[6] alongside contributing to several published books as a guest writer/editor.
Roy's current research includes gaining a clearer understanding around the blue tongue virus at a molecular level, the potential for developing vaccines for Bluetongue virus and the African Horse sickness virus, RNA-RNA interactions and packaging, cell entry and transcription activation of non-enveloped dsRNA viruses and defining the cis and trans acting factors in the assembly of the Bluetongue virus.